Akebia Therapeutics Inc (NASDAQ:AKBA)

0.4047
Delayed Data
As of Aug 05
 -0.0053 / -1.29%
Today’s Change
0.30
Today|||52-Week Range
3.35
-82.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.001.5M178.0M207.7M
 
 
 
 
Cost of Goods Sold0.00--0.006.3M
 
 
Depreciation And Amortization96.0K296.0K617.0K2.4M
 
 
 
 
 
 
Operating ExpensesGross Income-96.0K--177.4M199.1M
 
 
 
 
General Expenses61.1M137.2M257.3M354.1M
 
 
 
 
 
Research And Development42.7M115.5M230.9M291.0M
 
 
 
 
 
Total Operating Expenses61.2M137.5M257.9M362.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.2M-136.0M-79.9M-155.1M
 
 
 
 
 
Extraordinary Charge-300.0K-500.0K0.00-23.1M
 
 
 
 
Other Expenses287.0K-188.0K204.0K81.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.7M-135.7M-76.9M-171.9M
 
 
 
 
 
Income Taxes0.000.000.00-28.3M
 
 
Net Income-60.7M-135.7M-76.9M-143.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.5M37.7M43.5M58.0M
 
 
 
 
 
Shares To Calculate EPS Diluted26.5M37.7M43.5M58.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.29-$3.60-$1.77-$2.47
 
 
 
 
 
EPS Diluted-$2.29-$3.60-$1.77-$2.47